Malignant Pleural Mesothelioma [clinicaltrials_resource:76a0ee08a3f988434cea9d0a61aa50c7]
clinicaltrials:NCT00165503Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate [clinicaltrials:NCT00165516]Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma [clinicaltrials:NCT00165555]Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma [clinicaltrials:NCT00272558]Dendritic Cell-based Immunotherapy in Mesothelioma [clinicaltrials:NCT00280982]Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma [clinicaltrials:NCT00386815]Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma [clinicaltrials:NCT00484276]clinicaltrials:NCT00571298clinicaltrials:NCT00652574Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [clinicaltrials:NCT00700336]An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma [clinicaltrials:NCT00738582]Short Neoadjuvant Hemithoracic IMRT for MPM [clinicaltrials:NCT00797719]Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma [clinicaltrials:NCT00886028]Response Evaluation in Malignant Pleural Mesothelioma [clinicaltrials:NCT00969098]clinicaltrials:NCT01024946NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed [clinicaltrials:NCT01098266]clinicaltrials:NCT01143545clinicaltrials:NCT01211275clinicaltrials:NCT01212367Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment [clinicaltrials:NCT01243632]clinicaltrials:NCT01265433clinicaltrials:NCT01279967Trimodality Therapy for Malignant Pleural Mesothelioma [clinicaltrials:NCT01343264]A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma [clinicaltrials:NCT01353482]Autologous Redirected RNA Meso-CIR T Cells [clinicaltrials:NCT01355965]A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma [clinicaltrials:NCT01486368]Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma [clinicaltrials:NCT01644994]clinicaltrials:NCT01675765Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. [clinicaltrials:NCT01721018]Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma [clinicaltrials:NCT01722149]Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients [clinicaltrials:NCT01865045]Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma [clinicaltrials:NCT01870609]clinicaltrials:NCT01890980Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma. [clinicaltrials:NCT02004028]clinicaltrials:NCT02049060clinicaltrials:NCT02054104clinicaltrials:NCT02194231Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma [clinicaltrials:NCT02269878]A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma [clinicaltrials:NCT02347917]clinicaltrials:NCT02369198
condition [clinicaltrials_vocabulary:condition]
Malignant Pleural Mesothelioma [clinicaltrials_resource:76a0ee08a3f988434cea9d0a61aa50c7]
Bio2RDF identifier
76a0ee08a3f988434cea9d0a61aa50c7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:76a0ee08a3f988434cea9d0a61aa50c7
identifier
clinicaltrials_resource:76a0ee08a3f988434cea9d0a61aa50c7
title
Malignant Pleural Mesothelioma
@en
label
Malignant Pleural Mesothelioma [clinicaltrials_resource:76a0ee08a3f988434cea9d0a61aa50c7]
@en